Delivery Order SPE2DB22D2206-SPE2DB25FHB77
Award Date 5/21/25
Potential Completion Date 5/22/25
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,483.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Aranespß 60 mcg/0.3 mL syringes on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside contract represents a small-value pharmaceutical supply transaction fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,502.24 to AmerisourceBergen Drug Corp for Aranesp 40 mcg/0.4 mL syringes on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award represents a continuation of the company's role as a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $6,635.76 for the supply of ARANESP 500 MCG/1 ML SYRINGEML. This award is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,889.66 on August 6, 2025, for the supply of Aranespâ„¢ 500 mcg/1 ml syringes. This firm fixed-price contract, which is scheduled for completion by August 7, 2025, was competitively awarded without set-aside restrictions and is being funded through the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense. The...
- This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ARANESP 100 MCG/0.5 ML SYRINGE 0.5ML. The award has a total ceiling value of $16,141.52 and an ultimate completion date of April 15, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,529.79 firm fixed-price delivery order is for Aranesp 300 MCG/0.6 ML syringes and has a completion date of January 3, 2024. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,378.10 firm fixed-price delivery order is for the supply of Aranesp 60 mcg/0.3 mL syringes, a medication used to treat anemia. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency awarded a $9,393.31 delivery order to AmerisourceBergen Drug Corp for Aransesp 500 mcg/1 ml syringes on September 9, 2025, with completion targeted for September 10, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,369.34, is for the provision of 4564313917 ARANESP 100 MCG/ML VIALML, a specialty medication. The delivery order has a firm fixed-price pricing type and an ultimate completion date of April 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit prime contractor, to provide 100 mcg/0.5 mL syringes of Aranesp, a specialty pharmaceutical product. The $9,429.48 order has a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the...